Possible site of action of CGRP antagonists in migraine

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Possible site of action of CGRP antagonists in migraine. / Tfelt-Hansen, Peer; Olesen, Jes.

I: Cephalalgia, Bind 31, Nr. 6, 2011, s. 748-50.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Tfelt-Hansen, P & Olesen, J 2011, 'Possible site of action of CGRP antagonists in migraine', Cephalalgia, bind 31, nr. 6, s. 748-50. https://doi.org/10.1177/0333102411398403

APA

Tfelt-Hansen, P., & Olesen, J. (2011). Possible site of action of CGRP antagonists in migraine. Cephalalgia, 31(6), 748-50. https://doi.org/10.1177/0333102411398403

Vancouver

Tfelt-Hansen P, Olesen J. Possible site of action of CGRP antagonists in migraine. Cephalalgia. 2011;31(6):748-50. https://doi.org/10.1177/0333102411398403

Author

Tfelt-Hansen, Peer ; Olesen, Jes. / Possible site of action of CGRP antagonists in migraine. I: Cephalalgia. 2011 ; Bind 31, Nr. 6. s. 748-50.

Bibtex

@article{f0e4fb4945194bef8707fc4769693fee,
title = "Possible site of action of CGRP antagonists in migraine",
abstract = "The calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent drugs. Both are effective in migraine but in doses much higher than would be predicted from receptor binding and other in vitro results. This could perhaps suggest an effect of CGRP antagonists behind the blood-brain barrier (BBB), i.e. in the central nervous system (CNS).",
author = "Peer Tfelt-Hansen and Jes Olesen",
year = "2011",
doi = "http://dx.doi.org/10.1177/0333102411398403",
language = "English",
volume = "31",
pages = "748--50",
journal = "Cephalalgia",
issn = "0800-1952",
publisher = "SAGE Publications",
number = "6",

}

RIS

TY - JOUR

T1 - Possible site of action of CGRP antagonists in migraine

AU - Tfelt-Hansen, Peer

AU - Olesen, Jes

PY - 2011

Y1 - 2011

N2 - The calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent drugs. Both are effective in migraine but in doses much higher than would be predicted from receptor binding and other in vitro results. This could perhaps suggest an effect of CGRP antagonists behind the blood-brain barrier (BBB), i.e. in the central nervous system (CNS).

AB - The calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent drugs. Both are effective in migraine but in doses much higher than would be predicted from receptor binding and other in vitro results. This could perhaps suggest an effect of CGRP antagonists behind the blood-brain barrier (BBB), i.e. in the central nervous system (CNS).

U2 - http://dx.doi.org/10.1177/0333102411398403

DO - http://dx.doi.org/10.1177/0333102411398403

M3 - Review

VL - 31

SP - 748

EP - 750

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 6

ER -

ID: 40186575